Articles from Labviva
Esteemed Life Sciences Leader Joins Board to Enhance Strategic Direction During Company Expansion
By Labviva · Via GlobeNewswire · April 3, 2025

Series B investment underscores high growth opportunity for AI in life sciences
By Labviva · Via GlobeNewswire · January 13, 2025

Company acknowledged for “pushing AI to the limits”
By Labviva · Via GlobeNewswire · October 10, 2024

Enterprise procure-to-payment provider advances AI automation for inventory and purchase intelligence
By Labviva · Via GlobeNewswire · September 19, 2024

University of California selects AI purchasing platform to accelerate scientific and research procurement for 10 campuses
By Labviva · Via GlobeNewswire · September 12, 2024

Labviva, the AI-driven life sciences procurement platform, today announced the appointment of three new executives to drive key functions. Emily Nault joins Labviva as Senior Vice President, Platform Sales and Commerce, Jonathan Sheffi will join Labviva as Vice President, Strategic Marketing and Neal Karasic as Vice President of Product.
By Labviva · Via Business Wire · May 2, 2023

Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures. The Series A funding brings the total amount raised since inception to $30 million.
By Labviva · Via Business Wire · March 27, 2023

Labviva, a leader in life sciences marketplace software that modernizes procurement practices today announced Gilson as a strategic supply partner. Gilson’s liquid handling, purification, and extraction solutions will be available through Labviva’s marketplace.
By Labviva · Via Business Wire · December 15, 2021

Labviva, a leading SaaS application for healthcare procurement today announced an $8M Series Seed capital raise to support further development of the platform with new product lines, including investment in operations and customer success platforms. The funding closed on June 2, 2021. Led by Senator Investment Group, with other new investment from B Capital Group | Ascent and continued participation from Glasswing Ventures which led previous rounds to date.
By Labviva · Via Business Wire · June 21, 2021